NEW Research—First randomised trial of #remdesivir for hospitalised patients who are critically ill with #COVID19 suggests antiviral drug is not associated with significant clinical benefits vs placebo: study of 237 adults from 10 hospitals in Wuhan (1/5) https://t.co/K0h0qj4okw pic.twitter.com/btIH3mTPCg

— The Lancet (@TheLancet) April 29, 2020